NewsRx

Search our medical news database

Frost & Sullivan

Recent developments reported by Frost & Sullivan

Published in Medicine and Law Weekly, September 28th, 2007

Recent developments reported by Frost & Sullivan.

This trend article is an immediate alert from NewsRx to identify the most recent news developments at Frost & Sullivan.

Report 1: An increasing demand for active lifestyles as patients refuse to be disabled by osteoarthritis is one of the primary drivers of the European osteoarthritis market. Patients are seeking pharmacological treatment options rather than undergo surgical procedures, and this is promoting the demand for osteoarthritis drugs in Europe, where around 35 to 40 million of the population suffer from this disease in varying degrees of severity.

New analysis from Frost...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook